Results 201 to 210 of about 208,685 (341)

Diastolic and autonomous dysfunction linked to heterogeneous myocardial repolarization and arrhythmia risk in patients with arterial hypertension and left ventricular hypertrophy

, 2017
A. P. Ivanov, E. A. Sayeda, I. A. Elgardt, N. S. Sdobnyakova   +3 more
openalex   +2 more sources

International Contrast Ultrasound Society Safety Round Table

Journal of Ultrasound in Medicine, EarlyView.
The international Contract Ultrasound Society (ICUS) held a round table discussion on the safety of ultrasound contrast agents for cardiology, radiology, and pediatrics on September 4, 2024. The panel included international experts on ultrasound contrast.
Richard G. Barr, Jordan Strom, Dirk A. Clevert, Stephanie R Wilson, Thomas Porter, Kassa Darge   +5 more
wiley   +1 more source

Clinically interpretable electrovectorcardiographic machine learning criteria for the detection of echocardiographic left ventricular hypertrophy. [PDF]

PLoS One
De la Garza-Salazar F, Egenriether B.
europepmc   +1 more source

Fetal Ductal Constriction, Pulmonary Hypertension and Atrial Septum Mobility

Journal of Ultrasound in Medicine, EarlyView.
Objectives Fetuses with ductal constriction (FDC), pulmonary hypertension and right ventricular overload after maternal exposure to PGE2 inhibitors—nonsteroidal anti‐inflammatory drugs (NSAIDs) or polyphenols (PF)—have increased septum primum excursion index (SPEI), the ratio between maximal septum primum displacement and left atrial diameter.
Paulo Zielinsky, Polyanna Henriques, Pedro Van Der Sand, Maria Antonia Saldanha, Gabriela Macelaro, Joana Nicoloso   +5 more
wiley   +1 more source

ECG markers of left ventricular hypertrophy indicate response to mavacamten in hypertrophic obstructive cardiomyopathy. [PDF]

Open Heart
Buehning F, Lerchner T, Vogel J, Kolk L, Vogel L, Seuthe K, Ferdinandy P, Mahabadi AA, Rassaf T, Michel L.   +9 more
europepmc   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source

Coronary vasodilator capacity in obesity and morbid obesity - divergent flow responses with left ventricular hypertrophy. [PDF]

Int J Cardiol Heart Vasc
Ozkan E, Dai L, Dehdashti F, Liu K, Schindler TH.   +4 more
europepmc   +1 more source

Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE Study. [PDF]

, 2008
Boman K, CHINALI, MARCELLO, Dahlöf B, DE SIMONE, GIOVANNI, Devereux RB, Gardin JM, Gerdts E, Nieminen MS, Papademetriou V, Wachtell K   +9 more
core   +1 more source

Clinical significance of echocardiographic left ventricular hypertrophy for predicting left atrial appendage thrombotic milieu in patients with atrial fibrillation and CHA2DS2-VASc scores of 0–2

Kentaro Minami, Tomoko Machino‐Ohtsuka, Tomofumi Nakatsukasa, Naoto Kawamatsu, Kimi Sato, Masayoshi Yamamoto, Hiro Yamasaki, Yasushi Kawakami, Tomoko Ishizu   +8 more
openalex   +1 more source

Hypertension Images: Electrocardiographic Left Ventricular Hypertrophy

, 2001
L. Michael Prisant
openalex   +2 more sources